Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Hyun Lee

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Molecular Pharmaceutics|April 3, 2009
A combined chemoimmunotherapy approach using a plasmid-doxorubicin complexVaishali Bagalkot, In-Hyun Lee, Mi Kyung Yu, et al.
Molecular Therapy. Nucleic Acids|May 19, 2023
Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteinsSeoyeon Jeong, Hwa-Ryeon Kim, June-Ha Shin, et al.
Journal of Materials Chemistry. B|April 9, 2020
Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapyPhei Er Saw, Sunghyun Kim, In-Hyun Lee, et al.
Advanced Healthcare Materials|March 22, 2014
Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapySukyung Ahn, In-Hyun Lee, Sukmo Kang, et al.
Molecular Cancer Therapeutics|December 20, 2007
Efficacy and tissue distribution of DHP107, an oral paclitaxel formulationJung Wan Hong, In-Hyun Lee, Young Hak Kwak, et al.
The Journal of Veterinary Medical Science|April 7, 2020
Use of oral paclitaxel for the treatment of bladder tumors in dogsHyung-Kyu Chae, Ji-In Yang, Ju-Hyun An, et al.
Cancer Research|March 1, 2014
A specific STAT3-binding peptide exerts antiproliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signalingDaejin Kim, In-Hyun Lee, Sunghyun Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 4, 2023
Novel molecule BBC0901 inhibits BRD4 and acts as a catabolic regulator in the pathogenesis of osteoarthritisHyemi Lee, Jiho Nam, Hahyeong Jang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 28, 2014
Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectinHyungjun Kim, Yonghyun Lee, In-Hyun Lee, et al.
Plos One|November 20, 2019
DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapyEunseo Jang, Minhee Son, Junhee Jang, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Molecular Pharmaceutics|April 3, 2009
A combined chemoimmunotherapy approach using a plasmid-doxorubicin complexVaishali Bagalkot, In-Hyun Lee, Mi Kyung Yu, et al.
Molecular Therapy. Nucleic Acids|May 19, 2023
Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteinsSeoyeon Jeong, Hwa-Ryeon Kim, June-Ha Shin, et al.
Journal of Materials Chemistry. B|April 9, 2020
Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapyPhei Er Saw, Sunghyun Kim, In-Hyun Lee, et al.
Advanced Healthcare Materials|March 22, 2014
Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapySukyung Ahn, In-Hyun Lee, Sukmo Kang, et al.
Molecular Cancer Therapeutics|December 20, 2007
Efficacy and tissue distribution of DHP107, an oral paclitaxel formulationJung Wan Hong, In-Hyun Lee, Young Hak Kwak, et al.
The Journal of Veterinary Medical Science|April 7, 2020
Use of oral paclitaxel for the treatment of bladder tumors in dogsHyung-Kyu Chae, Ji-In Yang, Ju-Hyun An, et al.
Cancer Research|March 1, 2014
A specific STAT3-binding peptide exerts antiproliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signalingDaejin Kim, In-Hyun Lee, Sunghyun Kim, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 4, 2023
Novel molecule BBC0901 inhibits BRD4 and acts as a catabolic regulator in the pathogenesis of osteoarthritisHyemi Lee, Jiho Nam, Hahyeong Jang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 28, 2014
Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectinHyungjun Kim, Yonghyun Lee, In-Hyun Lee, et al.
Plos One|November 20, 2019
DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapyEunseo Jang, Minhee Son, Junhee Jang, et al.
Pageof 3